Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Chlorpropamide | Magnesium ascorbate may decrease the excretion rate of Chlorpropamide which could result in a higher serum level. |
| Mecamylamine | Magnesium ascorbate may increase the excretion rate of Mecamylamine which could result in a lower serum level and potentially a reduction in efficacy. |
| Amphetamine | The serum concentration of Amphetamine can be decreased when it is combined with Magnesium ascorbate. |
| Phentermine | The serum concentration of Phentermine can be decreased when it is combined with Magnesium ascorbate. |
| Pseudoephedrine | The serum concentration of Pseudoephedrine can be decreased when it is combined with Magnesium ascorbate. |
| Benzphetamine | The serum concentration of Benzphetamine can be decreased when it is combined with Magnesium ascorbate. |
| Diethylpropion | The serum concentration of Diethylpropion can be decreased when it is combined with Magnesium ascorbate. |
| Lisdexamfetamine | The serum concentration of Lisdexamfetamine can be decreased when it is combined with Magnesium ascorbate. |
| Mephentermine | The serum concentration of Mephentermine can be decreased when it is combined with Magnesium ascorbate. |
| MMDA | The serum concentration of MMDA can be decreased when it is combined with Magnesium ascorbate. |
| Midomafetamine | The serum concentration of Midomafetamine can be decreased when it is combined with Magnesium ascorbate. |
| 2,5-Dimethoxy-4-ethylamphetamine | The serum concentration of 2,5-Dimethoxy-4-ethylamphetamine can be decreased when it is combined with Magnesium ascorbate. |
| 4-Bromo-2,5-dimethoxyamphetamine | The serum concentration of 4-Bromo-2,5-dimethoxyamphetamine can be decreased when it is combined with Magnesium ascorbate. |
| Tenamfetamine | The serum concentration of Tenamfetamine can be decreased when it is combined with Magnesium ascorbate. |
| Chlorphentermine | The serum concentration of Chlorphentermine can be decreased when it is combined with Magnesium ascorbate. |
| Methylenedioxyethamphetamine | The serum concentration of Methylenedioxyethamphetamine can be decreased when it is combined with Magnesium ascorbate. |
| Dextroamphetamine | The serum concentration of Dextroamphetamine can be decreased when it is combined with Magnesium ascorbate. |
| Metamfetamine | The serum concentration of Metamfetamine can be decreased when it is combined with Magnesium ascorbate. |
| Iofetamine I-123 | The serum concentration of Iofetamine I-123 can be decreased when it is combined with Magnesium ascorbate. |
| Ritobegron | The serum concentration of Ritobegron can be decreased when it is combined with Magnesium ascorbate. |
| Mephedrone | The serum concentration of Mephedrone can be decreased when it is combined with Magnesium ascorbate. |
| Methoxyphenamine | The serum concentration of Methoxyphenamine can be decreased when it is combined with Magnesium ascorbate. |
| Gepefrine | The serum concentration of Gepefrine can be decreased when it is combined with Magnesium ascorbate. |
| 2,5-Dimethoxy-4-ethylthioamphetamine | The serum concentration of 2,5-Dimethoxy-4-ethylthioamphetamine can be decreased when it is combined with Magnesium ascorbate. |
| Phendimetrazine | The serum concentration of Phendimetrazine can be decreased when it is combined with Magnesium ascorbate. |